The Association of the British Pharmaceutical Industry (ABPI) has published a new guide to how the pharmaceutical industry can support healthcare professionals (HCPs) with prescribing decisions. The ...
AstraZeneca’s (AZ) Tagrisso (osimertinib) has been approved by the US Food and Drug Administration (FDA) in combination with ...
Launched in 2018, the All of Us Research Program aims to gather health data from one million or more people living in the US to accelerate research and improve health. So far, more than 750,000 people ...
Astellas has announced that its subsidiary, Xyphos Biosciences, has entered into a research collaboration and license ...
Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs. In terms of creative output, pharma brand sites are often not the most exciting, but they’re a ...
PrecisionLife and the Metrodora Institute have announced a collaboration to accelerate the diagnosis and treatment of a range of complex chronic diseases. The partnership will focus on conditions ...
As technology advances there is a growing array of MedTech solutions – wearables, voice-activated devices, telehealth, etc. – to better support patients in their daily lives. However, MedTech research ...
Researchers publish medical advances every day, and part of a clinician’s role is to stay up-to-date with the latest information on diagnosis, treatment and care. This can make a significant ...
UCB's bimekizumab has demonstrated sustained efficacy and symptom improvement in patients with hidradenitis suppurativa (HS), according to late-stage results presented at this year’s Conference of the ...
Sanofi has announced that its investigational anti-CD40L antibody frexalimab has shown potential as a “high-efficacy therapy" for relapsing multiple sclerosis (MS), according to mid-stage results ...
Takeda’s Eohilia (budesonide oral suspension) has been approved by the US Food and Drug Administration (FDA) as the first and only oral therapy for eosinophilic oesophagitis (EoE) in the US. The ...
The European Commission (EC) has granted conditional marketing authorisation to Vertex Pharmaceuticals and CRISPR Therapeutics’ gene therapy for use in transfusion-dependent beta thalassaemia (TDT) ...